You just read:

Regeneron and Sanofi Present Results from Phase 3 MONARCH Study of Investigational Sarilumab at American College of Rheumatology Annual Meeting

News provided by

Regeneron Pharmaceuticals, Inc.

Nov 16, 2016, 08:00 ET